Zhejiang Garden Biopharmaceutical Co.,Ltd. (SHE:300401)
China flag China · Delayed Price · Currency is CNY
13.21
+0.06 (0.46%)
Apr 29, 2026, 3:04 PM CST

SHE:300401 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
1,1881,2371,2211,0821,3971,107
Other Revenue
--22.4512.9320.399.75
1,1881,2371,2431,0951,4181,117
Revenue Growth (YoY)
-4.16%-0.47%13.58%-22.78%26.89%69.40%
Cost of Revenue
549.64549.06519.59441.4486.37350.66
Gross Profit
638.25688.34723.7653.25931.14766.44
Selling, General & Admin
222.84236.95308.87378.77444.55257.61
Research & Development
72.4365.4683.7890.9170.3459.28
Other Operating Expenses
4.242.913.2416.4416.243.48
Operating Expenses
299.51305.31407.87483.74533.66320.69
Operating Income
338.74383.03315.83169.51397.48445.75
Interest Expense
---35.63-38.41-21.82-10.81
Interest & Investment Income
1.551.4111.0120.5413.7532.49
Currency Exchange Gain (Loss)
--6.317.0211.1-2.79
Other Non Operating Income (Expenses)
-36.67-26.5-0.32-0.3-0.65-0.19
EBT Excluding Unusual Items
303.62357.93297.19158.36399.86464.46
Gain (Loss) on Sale of Investments
3.233.770.25-0.34-2.830.4
Gain (Loss) on Sale of Assets
-2.24-2.2431.53-0.0417.876.22
Asset Writedown
-6.95-6.96-0.44-0.22-1.01-0.09
Other Unusual Items
--30.1753.2728.6748.38
Pretax Income
297.67352.5358.69211.04442.48589.37
Income Tax Expense
39.0547.6449.4818.758.7675.42
Earnings From Continuing Operations
258.62304.86309.21192.35383.72513.94
Minority Interest in Earnings
0.010.010---30.18
Net Income
258.62304.86309.21192.35383.72483.77
Net Income to Common
258.62304.86309.21192.35383.72483.77
Net Income Growth
-17.70%-1.41%60.76%-49.87%-20.68%83.79%
Shares Outstanding (Basic)
550544542550548544
Shares Outstanding (Diluted)
603598595601548544
Shares Change (YoY)
4.71%0.53%-1.07%9.65%0.85%7.38%
EPS (Basic)
0.470.560.570.350.700.89
EPS (Diluted)
0.430.510.520.320.700.89
EPS Growth
-21.40%-1.92%62.50%-54.29%-21.35%71.15%
Free Cash Flow
197.07112.78-13.97-84.57-2.89-203.33
Free Cash Flow Per Share
0.330.19-0.02-0.14-0.01-0.37
Dividend Per Share
--0.1140.0710.1400.188
Dividend Growth
--60.56%-49.29%-25.53%82.52%
Gross Margin
53.73%55.63%58.21%59.68%65.69%68.61%
Operating Margin
28.52%30.95%25.40%15.48%28.04%39.90%
Profit Margin
21.77%24.64%24.87%17.57%27.07%43.31%
Free Cash Flow Margin
16.59%9.11%-1.12%-7.72%-0.20%-18.20%
EBITDA
522.8561.37471.35302.82458.27490.2
EBITDA Margin
44.01%45.37%37.91%27.66%32.33%43.88%
D&A For EBITDA
184.05178.35155.52133.3160.7944.45
EBIT
338.74383.03315.83169.51397.48445.75
EBIT Margin
28.52%30.95%25.40%15.48%28.04%39.90%
Effective Tax Rate
13.12%13.52%13.80%8.86%13.28%12.80%
Revenue as Reported
--1,2431,0951,4181,117
Advertising Expenses
--2.370.970.70.8
Updated Mar 31, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.